Trials / Active Not Recruiting
Active Not RecruitingNCT06449768
Effectiveness Of Suprachoroidal Injection In Diabetic Macular Edema
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (actual)
- Sponsor
- Superior University · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
It will investigate a novel treatment approach for diabetic macular edema (DME), which causes vision impairment in diabetic patients. It will focuse on the efficacy and safety of administering triamcinolone acetonide via suprachoroidal injection, targeting the space between the sclera and choroid.
Detailed description
This method aims to enhance drug delivery to the retina, potentially improving outcomes compared to conventional treatments. Participants receive suprachoroidal injections, and the study measures changes in macular thickness and visual acuity. The study's findings could offer a promising alternative to existing DME treatments, aiming to provide better management of the condition and improved patient quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Diabetic Macular Edema | observing the eye behavior in Diabetic Macular Edema |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-05-01
- Completion
- 2024-10-28
- First posted
- 2024-06-10
- Last updated
- 2024-06-10
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06449768. Inclusion in this directory is not an endorsement.